Eagle Pharmaceuticals
EGRX
#9847
Rank
NZ$39.24 M
Marketcap
$3.03
Share price
0.00%
Change (1 day)
-60.03%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): NZ$56.84 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2022 the company made an earning of NZ$0.11 Billion, an increase over its 2021 earnings that were of -NZ$4.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) NZ$56.84 M-48.71%
2022 NZ$0.11 B-2361.45%
2021 -NZ$4.91 Million-111.53%
2020 NZ$42.48 M2.31%
2019 NZ$41.52 M-32.89%
2018 NZ$61.87 M-50.35%
2017 NZ$0.12 B38.63%
2016 NZ$89.9 M1966.43%
2015 NZ$4.35 M-111.46%
2014 -NZ$37.98 Million282.82%
2013 -NZ$9.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$29.34 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.39 B 12,223.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$22.94 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$0.48 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$7.75 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.33 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.1 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA